Company intelligence / Profile preview

Ferrosan

Ownership: Private
Employees: ~430
Development stage: Commercial

Overview

Ferrosan Medical Devices is a global leader in developing and manufacturing adjunctive haemostatic products used to control surgical bleeding. Their products are widely used in operating rooms worldwide under brands such as SURGIFLO™, SPONGOSTAN™, and SURGIFOAM®, distributed through Ethicon (Johnson & Johnson). They also develop advanced breast biopsy devices for cancer diagnostics. The company has achieved MDR certifications for its products.

Therapeutic areas: HematologyOncology
Modalities: Biomaterial-based deviceEnzyme-based deviceElectromechanical medical device
Industry: Surgical Medical Devices

Partnerships

Ethicon (Johnson & Johnson) – global sales/distribution of haemostatic products under major brandsGlobal partner for distribution of breast biopsy devices (not named)

Beyond the preview

Go deeper on Ferrosan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferrosan.

Explore the full profile